Therese White
National Institutes of Health
20 Papers
91 Citations
Therese White is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Chronic lymphocytic leukemia & Rituximab. The author has an hindex of 10, co-authored 20 publications. Previous affiliations of Therese White include University of Texas MD Anderson Cancer Center.
Chat about Author
Papers
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu,Patricia Pérez-Galán,Delong Liu,Angelique Biancotto,Stefania Pittaluga,Berengere Vire,Federica Gibellini,Ndegwa Njuguna,Elinor Lee,Lawrence S. Stennett,Nalini Raghavachari,Poching Liu,J. Philip McCoy,Mark Raffeld,Maryalice Stetler-Stevenson,Constance M. Yuan,Richard M. Sherry,Diane C. Arthur,Irina Maric,Therese White,Gerald E. Marti,Peter J. Munson,Wyndham H. Wilson,Adrian Wiestner +23 more
TL;DR: The disruption of tumor microenvironment interactions and the inhibition of BCR signaling as promising therapeutic strategies in CLL are identified.
868
Lymphomatoid granulomatosis, a single institute experience: pathologic findings and clinical correlations
Joo Y. Song,Stefania Pittaluga,Kieron Dunleavy,Nicole Grant,Therese White,Liuyan Jiang,Theresa Davies-Hill,Mark Raffeld,Wyndham H. Wilson,Elaine S. Jaffe +9 more
TL;DR: Lymphomatoid granulomatosis is a distinct entity that can usually be differentiated from other EBV-associated B-cell lymphoproliferative disorders on the basis of the combination of clinical presentation, histology, and EBV studies.
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma
Sattva S. Neelapu,Sattva S. Neelapu,Larry W. Kwak,Larry W. Kwak,Carol B. Kobrin,Craig W. Reynolds,John E. Janik,Kieron Dunleavy,Therese White,Linda K. Harvey,Robin Pennington,Maryalice Stetler-Stevenson,Elaine S. Jaffe,Seth M. Steinberg,Ronald E. Gress,Frances T. Hakim,Wyndham H. Wilson +16 more
TL;DR: Assessment of immune responses to a well-characterized idiotype vaccine in individuals with severe B-cell depletion but normal T cells after CD20-specific antibody–based chemotherapy of mantle cell lymphoma in first remission shows that severe B -cell depletion does not impair T-cell priming in humans.
116
Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.
Gerald E. Marti,Maryalice Stetler-Stevenson,Nicole Grant,Therese White,William D. Figg,Tanyifor M. Tohnya,Elaine S. Jaffe,Kieron Dunleavy,John E. Janik,Seth M. Steinberg,Wyndham H. Wilson +10 more
TL;DR: Transient lymphocytosis followed by apoptosis occurs with UCN-01 and Mobilization from tissue reservoirs may play a role in the induction of cell death in malignant lymphocytes in relapsed lymphoma.
27
Phase I/II study of Bortezomib Alone and Bortezomib with Dose-Adjusted EPOCH Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma.
Kieron Dunleavy,John E. Janik,Juan Gea-Banacloche,Margaret Shovlin,Therese White,Neta Goldschmidt,Nicole Grant,Omer N. Koc,Stefania Pittaluga,Elaine S. Jaffe,Louis M. Staudt,Wyndham H. Wilson +11 more
TL;DR: Bortezomib can be safely combined with combination chemotherapy but does not appear to increase the efficacy of DA-EPOCH chemotherapy in relapsed/refractory DLBCL.
24